MoneyWorks4Me

Merck Board to consider interim dividend

10 Jan 2014 Evaluate

Merck has informed that a meeting of the Board of Directors of the Company will be held on January 31, 2014 to consider and approve the Audited Financial Results for the quarter & year ended December 31, 2013 and to consider recommendation of dividend for the year 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..